collection
https://read.qxmd.com/read/35636830/2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure-developed-by-the-task-force-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure-of-the-european-society-of-cardiology-esc-with-the-special-contribution-of
#21
Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel, John G F Cleland, Andrew J S Coats, Maria G Crespo-Leiro, Dimitrios Farmakis, Martine Gilard, Stephane Heymans, Arno W Hoes, Tiny Jaarsma, Ewa A Jankowska, Mitja Lainscak, Carolyn S P Lam, Alexander R Lyon, John J V McMurray, Alexandre Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, Giuseppe M C Rosano, Frank Ruschitzka, Anne Kathrine Skibelund
No abstract text is available yet for this article.
June 2022: Revista Española de Cardiología
https://read.qxmd.com/read/36227147/effect-of-preoperative-extracorporeal-membrane-oxygenation-therapy-on-postventricular-assist-device-outcomes-an-analysis-of-the-sts-pedimacs-database
#22
JOURNAL ARTICLE
Syed M Peer, Devin A Koehl, Ryan S Cantor, James K Kirklin, Pranava Sinha
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) support prior to ventricular assist device (VAD) therapy is frequently used for stabilizing INTERMACS 1 and 2 paediatric patients. Data regarding outcomes with this strategy is limited. METHODS: Patient characteristics and outcomes post-VAD therapy with and without preop ECMO support were compared. Survival and risk factor analysis was performed for all patients and INTERMACS profile 1 subgroup. RESULTS: Of 541 INTERMACS 1 and 2 patients enrolled in Paediatric Interagency Registry for Mechanical Circulatory Support registry, 391 received primary VAD implantation and ECMO prior to VAD therapy was utilized in 150 patients...
November 3, 2022: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/36263076/mechanical-circulatory-support-for-acute-heart-failure-complicated-by-cardiogenic-shock
#23
REVIEW
Min Suk Choi, Hunbo Shim, Yang Hyun Cho
Acute heart failure is a potentially life-threatening condition that can lead to cardiogenic shock, which is associated with hypotension and organ failure. Although there have been many studies on the treatment for cardiogenic shock, early mortality remains high at 40-50%. No new medicines for cardiogenic shock have been developed. Recently, there has been a gradual decline in the use of the intra-aortic balloon pump mainly due to a lack of adequate hemodynamic support. Extracorporeal membrane oxygenation and the percutaneous ventricular assist device have become more widely used in recent years...
January 2020: International journal of heart failure
https://read.qxmd.com/read/36275352/a-comprehensive-review-of-mechanical-circulatory-support-devices
#24
REVIEW
Varunsiri Atti, Mahesh Anantha Narayanan, Brijesh Patel, Sudarshan Balla, Aleem Siddique, Scott Lundgren, Poonam Velagapudi
Treatment strategies to combat cardiogenic shock (CS) have remained stagnant over the past decade. Mortality rates among patients who suffer CS after acute myocardial infarction (AMI) remain high at 50%. Mechanical circulatory support (MCS) devices have evolved as novel treatment strategies to restore systemic perfusion to allow cardiac recovery in the short term, or as durable support devices in refractory heart failure in the long term. Haemodynamic parameters derived from right heart catheterization assist in the selection of an appropriate MCS device and escalation of mechanical support where needed...
2022: Heart International
https://read.qxmd.com/read/36174742/impella-versus-extracorporeal-membranous-oxygenation-ecmo-for-cardiogenic-shock-a-systematic-review-and-meta-analysis
#25
REVIEW
Soban Ahmad, Muhammad Junaid Ahsan, Sundus Ikram, Noman Lateef, Behram A Khan, Shehroze Tabassum, Aroma Naeem, Ahmed H Qavi, Sivakumar Ardhanari, Andrew M Goldsweig
The use of mechanical circulatory support (MCS) in cardiogenic shock (CS) is increasing. We conducted a systematic review and meta-analysis to compare the outcomes of Impella use with extracorporeal membranous oxygenation (ECMO) support in patients with CS. We searched the Medline, EMBASE, Cochrane, and Clinicaltrials.gov databases for observational studies comparing Impella to ECMO in patients with CS. Risk ratios (RRs) for categorical variables and standardized mean differences (SMDs) for continuous variables were calculated with 95% confidence intervals (CIs) using a random-effects model...
January 2023: Current Problems in Cardiology
https://read.qxmd.com/read/36200273/selection-of-percutaneous-mechanical-circulatory-support-in-cardiogenic-shock-patient-specific-considerations-and-insights-from-contemporary-clinical-data
#26
REVIEW
Mary E Acosta, Mark N Belkin, Sandeep Nathan
PURPOSE OF REVIEW: Cardiogenic shock remains a complex and variable disease process requiring early recognition and prompt, multidisciplinary treatment. Available data link usage of high-dose and/or multiple vasopressors in cardiogenic shock to increased mortality. This review proposes a structured approach to escalation of percutaneous mechanical circulatory support (pMCS) in cardiogenic shock, based on the hemodynamic and metabolic parameters highlighted in the revised SCAI Shock Classification, and supported by the available clinical data...
January 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/36211548/mechanical-circulatory-support-devices-and-treatment-strategies-for-right-heart-failure
#27
REVIEW
Taiyo Kuroda, Chihiro Miyagi, Kiyotaka Fukamachi, Jamshid H Karimov
The importance of right heart failure (RHF) treatment is magnified over the years due to the increased risk of mortality. Additionally, the multifactorial origin and pathophysiological mechanisms of RHF render this clinical condition and the choices for appropriate therapeutic target strategies remain to be complex. The recent change in the United Network for Organ Sharing (UNOS) allocation criteria of heart transplant may have impacted for the number of left ventricular assist devices (LVADs), but LVADs still have been widely used to treat advanced heart failure, and 4...
2022: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/35461760/temporary-mechanical-circulatory-support-devices-outcomes-and-future-directions
#28
REVIEW
David A Baran, Abhishek Jaiswal, Felix Hennig, Evgenij Potapov
Faced with a chronic donor shortage, clinicians and regulators both struggle to develop allocation systems which balance the challenges of waitlist mortality and donor availability. Most organ allocation systems across the globe have prioritized transplantation of patients supported on temporary mechanical circulatory support (tMCS) with regional variations. There are concerns that this approach might not produce optimal outcomes and is not without major drawbacks including lack of strict criteria for tMCS as bridge strategy, choice of optimal devices and wait time on tMCS...
June 2022: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/36008179/less-is-better-comparing-effects-of-median-sternotomy-and-thoracotomy-surgical-approaches-for-left-ventricular-assist-device-implantation-on-postoperative-outcomes-and-valvulopathy
#29
JOURNAL ARTICLE
Alice Vinogradsky, Yuming Ning, Paul Kurlansky, Michael Kirschner, Melana Yuzefpolskaya, Paolo Colombo, Gabriel Sayer, Nir Uriel, Yoshifumi Naka, Koji Takeda
OBJECTIVE: Our objective was to compare outcomes after left ventricular assist device implantation performed via median sternotomy or lateral thoracotomy. METHODS: We retrospectively analyzed 222 adult patients with the HeartMate3 (Abbott Lab) left ventricular assist device implanted between November 2014 and November 2021. Outcomes stratified by surgical approach were evaluated in propensity score-matched groups. The primary outcome was 1-year survival. Secondary outcomes included in-hospital morbidity and mortality, readmissions, and significant valvular regurgitation...
May 17, 2022: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/35689617/the-parasternal-technique-alternative-technique-for-temporary-right-ventricular-assist-device-implantation
#30
JOURNAL ARTICLE
Stefan H Feder, Khalil Jawad, Michael A Borger, Diyar Saeed
Right heart failure is a feared complication in cardiac surgery especially after heart failure surgery. Right ventricular assist device (RVAD) implantation is inevitable in severe forms of right heart failure. Different techniques for RVAD implantation exist. We here present our experience with a novel parasternal cannulation technique that allows early mobilization, high RVAD flow rates and easy RVAD removal.
June 15, 2022: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/35999070/meta-analysis-comparing-venoarterial-extracorporeal-membrane-oxygenation-with-or-without-impella-in-patients-with-cardiogenic-shock
#31
JOURNAL ARTICLE
Kirtipal Bhatia, Vardhmaan Jain, Michael J Hendrickson, Devika Aggarwal, Jose S Aguilar-Gallardo, Persio D Lopez, Bharat Narasimhan, Lingling Wu, Sameer Arora, Aditya Joshi, Matthew I Tomey, Kiran Mahmood, Arman Qamar, Edo Y Birati, Arieh Fox
Cardiogenic shock is associated with high short-term mortality. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used as a mechanical circulatory support strategy for patients with refractory cardiogenic shock. A drawback of this hemodynamic support strategy is increased left ventricular (LV) afterload, which is mitigated by concomitant use of Impella (extracorporeal membrane oxygenation with Impella [ECPELLA]). However, data regarding the benefits of this approach are limited. We conducted a systematic search of Medline, EMBASE, and Cochrane databases to identify studies including patients with cardiogenic shock reporting clinical outcomes with Impella plus VA-ECMO compared with VA-ECMO alone...
October 15, 2022: American Journal of Cardiology
https://read.qxmd.com/read/35844254/pulmonary-artery-cannulation-during-venovenous-extracorporeal-membrane-oxygenation-an-alternative-to-manage-refractory-hypoxemia-and-right-ventricular-dysfunction
#32
Gustavo Rojas-Velasco, Patricia Carmona-Levario, Daniel Manzur-Sandoval, Emmanuel Lazcano-Díaz, Félix Damas-de Los Santos
Venovenous extracorporeal membrane oxygenation (ECMO) has become a rescue therapy for acute respiratory distress syndrome (ARDS) secondary to COVID-19 for patients who are refractory to conventional therapy. However, this therapy comes with complications, and alternative cannulation strategies are needed to overcome these difficulties. In this article, we present a case of venovenous ECMO presenting with refractory hypoxemia and right ventricular dysfunction, which were corrected by cannulating the pulmonary artery...
2022: Respiratory Medicine Case Reports
https://read.qxmd.com/read/35938789/insertion-maintenance-and-removal-of-the-percutaneous-dual-lumen-cannula-right-ventricular-assist-device
#33
JOURNAL ARTICLE
Kristen N Brown, Anthony Castleberry, Poonam Velagapudi
Right ventricular (RV) shock, classically characterized by elevated central venous pressure (CVP) with normal to low pulmonary artery (PA) and pulmonary capillary wedge pressures (PCWP), remains a significant cause of morbidity and mortality worldwide if left untreated. Therapies for the treatment of RV shock range from medical management to durable or percutaneous mechanical circulatory support (MCS). A unique MCS device, a percutaneous right ventricular assist device (pRVAD), approved for use by the Food and Drug Administration (FDA) in 2014, works by temporarily off-loading the RV through a single, dual lumen catheter with extracorporeal mechanical support and is capable of shunting blood from the right atrium (RA) to the main PA...
July 20, 2022: Journal of Visualized Experiments: JoVE
https://read.qxmd.com/read/35956219/how-to-optimize-ecls-results-beyond-ventricular-unloading-from-ecmo-to-centrimag-%C3%A2-evad
#34
JOURNAL ARTICLE
Vincenzo Tarzia, Lorenzo Bagozzi, Matteo Ponzoni, Giacomo Bortolussi, Giulio Folino, Roberto Bianco, Fabio Zanella, Tomaso Bottio, Gino Gerosa
CentriMag® extracorporeal VAD support could represent a more physiological choice than conventional ECMO in primary cardiogenic shock. We therefore evaluated the outcome of patients with primary cardiogenic shock who were supported with CentriMag® extracorporeal VAD implantation versus conventional ECMO. We retrospectively reviewed all extracorporeal life supports implanted for primary cardiogenic shock between January 2009 and December 2018 at our institution. Among 212 patients, 143 cases (67%) were treated exclusively with ECMO (Group 1) and 69 cases (33%) with extracorporeal VAD implantation (Group 2, 48 of whom as conversion of ECMO)...
August 7, 2022: Journal of Clinical Medicine
https://read.qxmd.com/read/35887718/impella-versus-venoarterial-extracorporeal-membrane-oxygenation-for-acute-myocardial-infarction-cardiogenic-shock-a-systematic-review-and-meta-analysis
#35
JOURNAL ARTICLE
Riley J Batchelor, Andrew Wheelahan, Wayne C Zheng, Dion Stub, Yang Yang, William Chan
OBJECTIVES: Despite an increase in the use of mechanical circulatory support (MCS) devices for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised data directly comparing the use of Impella and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO). METHODS: Electronic databases of MEDLINE, EMBASE and CENTRAL were systematically searched in November 2021. Studies directly comparing the use of Impella (CP, 2.5 or 5.0) with VA-ECMO for AMI-CS were included...
July 7, 2022: Journal of Clinical Medicine
https://read.qxmd.com/read/35895989/mechanical-circulatory-assist-devices-which-is-the-best-device-as-bridge-to-heart-transplantation
#36
REVIEW
Adriana Natucci Hette, Marcelo Luiz Peixoto Sobral
INTRODUCTION: Heart transplantation is the recommended treatment method for patients with advanced heart failure that is refractory to clinical treatment. Due to the progressive severity of these patients and the impossibility of performing the transplant in a short term, there are mechanical circulatory assist devices that can offer necessary hemodynamic support and clinical stability in the period preceding the heart transplant surgery. The present study aims to address and describe the main devices used as bridges for heart transplantation, as well as to analyze their advantages and disadvantages...
October 8, 2022: Brazilian Journal of Cardiovascular Surgery
https://read.qxmd.com/read/35766587/the-role-of-temporary-mechanical-circulatory-support-as-a-bridge-to-advanced-heart-failure-therapies-or-recovery
#37
REVIEW
Daniel Oren, Robert Zilinyi, Dor Lotan, Matan Uriel, Nir Uriel, Gabriel Sayer
PURPOSE OF REVIEW: Temporary mechanical circulatory support (tMCS) has become central in the treatment of refractory cardiogenic shock and can be used to bridge patients to durable MCS, heart transplant or recovery. This review will discuss contemporary data regarding bridging strategies utilizing tMCS. RECENT FINDINGS: There has been significant growth in tMCS use recently, driven by increased familiarity with tMCS devices, and increased experience with both implantation and management...
September 1, 2022: Current Opinion in Cardiology
https://read.qxmd.com/read/33879383/percutaneous-rvad-with-the-protek-duo-for-severe-right-ventricular-primary-graft-dysfunction-after-heart-transplant
#38
JOURNAL ARTICLE
Massimiliano Carrozzini, Bruno Merlanti, Guido Maria Olivieri, Marco Lanfranconi, Giuseppe Bruschi, Michele Mondino, Claudio Francesco Russo
Right ventricular primary graft dysfunction after heart transplant is a serious life-threatening condition. The severe form, refractory to maximal medical therapy, has traditionally required temporary mechanical support through veno-arterial extracorporeal membrane oxygenation or central right ventricular support. The Protek Duo is a dual lumen cannula recently introduced in the market, which allows for the institution of a percutaneous right ventricular support. We present the first promising case series of the use of this novel support in patients with right ventricular primary graft dysfunction after heart transplant...
July 2021: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/34313320/percutaneous-venopulmonary-artery-extracorporeal-membrane-oxygenation-for-right-heart-failure-after-left-ventricular-assist-device-insertion
#39
JOURNAL ARTICLE
Yashutosh Joshi, Marie-Cecile Bories, Nadia Aissaoui, Jean-Michel Grinda, Alain Bel, Christian Latremouille, Jérôme Jouan
OBJECTIVES: Right ventricular failure after left ventricular assist device (LVAD) insertion is associated with significant mortality and morbidity. Mechanical support options include right ventricular assist devices, venoarterial extracorporeal membrane oxygenation (ECMO) and venopulmonary artery ECMO, the latter often involving central cannulation. We sought to evaluate the feasibility and early outcomes of a truly percutaneous venopulmonary artery (pVPA) ECMO strategy, with the potential advantage of bedside removal once weaned...
November 22, 2021: Interactive Cardiovascular and Thoracic Surgery
https://read.qxmd.com/read/33003068/impella-5-5-versus-centrimag-a-head-to-head-comparison-of-device-hemocompatibility
#40
JOURNAL ARTICLE
Yana Roka-Moiia, Mengtang Li, Adriana Ivich, Sami Muslmani, Karl B Kern, Marvin J Slepian
Despite growing use of mechanical circulatory support, limitations remain related to hemocompatibility. Here, we performed a head-to-head comparison of the hemocompatibility of a centrifugal cardiac assist system-the Centrimag, with that of the latest generation of an intravascular microaxial system-the Impella 5.5. Specifically, hemolysis, platelet activation, microparticle (MP) generation, and von Willebrand factor (vWF) degradation were evaluated for both devices. Freshly obtained porcine blood was recirculated within device propelled mock loops for 4 hours, and alteration of the hemocompatibility parameters was monitored over time...
September 29, 2020: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
label_collection
label_collection
4810
2
3
2022-04-22 13:51:24
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.